Mannose-binding lectin is a disease-modifying factor in north American patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 34, Issue 7, 2007, Pages 1506-1513

  Piao, Wenhua ^a,c   Lui, Chau Ching ^a,c   Kao, Amy H ^a,b,c   Manzi, Susan ^a,b,c   Vogt, Molly T ^c   Ruffing, Margie J ^a,c   Ahearn, Joseph M ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibody production; Genetic polymorphism; Mannose binding lectin; Systemic lupus erythematosus

Indexed keywords

MANNOSE BINDING LECTIN; PHOSPHOLIPID; RO ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN; PENNSYLVANIA; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 34447540001     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000;76:227-324.
2. Barilla-LaBarca ML, Atkinson JP. Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 2003;15:55-60.
3. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431-56.
4. Sullivan KE, Wisnieski JJ, Winkelstein JA, et al. Serum complement determinations in patients with quiescent systemic lupus erythematosus. J Rheumatol 1996;23:2063-7.
5. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2004;40:423-9.
6. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004;16:794-800.
7. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989;262:763-71.
8. Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000;2:305-22.
9. Turner MW, Lipscombe RJ, Levinsky RJ, et al. Mutations in the human mannose binding protein gene: their frequencies in three distinct populations and relationship to serum levels of the protein. Immunodeficiency 1993;4:285-7.
10. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003;40:73-84.
11. Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991;337:1569-70.
12. Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994;40:37-44.
13. Lipscombe RJ, Beatty DW, Ganczakowski M, et al. Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996;4:13-9.
14. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
15. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:2046-51.
16. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 1998;41:1663-8.
17. Tsutsumi A, Sasaki K, Wakamiya N, et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immunol 2001;2:99-104.
18. Takahashi R, Tsutsumi A, Ohtani K, et al. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 2005;64:311-4.
19. Sullivan KE, Jawad AF, Piliero LM, et al. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology Oxford 2003;42:446-52.
20. Davies EJ, Teh LS, Ordi-Ros J, et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol 1997;24:485-8.
21. Davies EJ, Snowden N, Hillarby MC, et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995;38:110-4.
22. Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999;42:2145-52.
23. Horiuchi T, Tsukamoto H, Morita C, et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immunol 2000;1:464-6.
24. Garcia-Laorden MI, Manzanedo A, Figuerola A, Sanchez-Garcia F, Rodriguez-Gallego C. Mannose-binding lectin polymorphisms in a Canary Islands (Spain) population. Genes Immunol 2001;2:292-4.
25. Seelen MA, van der Bijl EA, Trouw LA, et al. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. Rheumatology Oxford 2005; 44:111-9.
26. Lee YH, Witte T, Momt T, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus. Two case-control studies and a meta-analysis. Arthritis Rheum 2005; 52:3966-74.
27. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
28. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997;40:1725.
29. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
31. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003;188:1394-403.
32. Hamajima N, Saito T, Matsuo K, Tajima K. Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers. J Mol Diagn 2002;4:103-7.
33. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995;85:660-7.
34. Naito H, Ma Y, Uemura K, Arano Y, Kawasaki T. Metabolic properties of normal and mutant mannan-binding proteins in mouse plasma. Biochem Biophys Res Commun 1999;256:231-4.
35. Wallis R, Cheng JY. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol 1999;163:4953-9.
36. Summerfield JA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-9.
37. Garred P, Madsen HO, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997;349:236-40.
38. Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 2005;4:364-72.
39. Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194:781-95.
40. Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003;33:2853-63.
41. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
42. Navratil JS, Ahearn JM. Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 2001;2:32-8.
43. White S, Rosen A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 2003;15:557-62.
44. Freedman BI, Wilson CH, Spray BJ, Turtle AB, Olorenshaw IM, Kammer GM. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997;29:729-32.
45. Bertoli AM, Fernandez M, McGwin GJ, et al. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum 2006;54:1703-4.
46. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004;351:260-7.
47. Momot T, Ahmadi-Simab K, Gause A, et al. Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus. Ann Rheum Dis 2006;65:278-9.
48. Calvo-Alen J, Alarcon GS, Tew MB, et al. Systemic lupus erythematosus in a multiethnic US cohort. XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum 2006;54:1940-5.
49. Davies EJ, Tikly M, Wordsworth BP, Ollier WE. Mannose-binding protein gene polymorphism in South African systemic lupus erythematosus. Br J Rheumatol 1998;37:465-6.
50. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:706-8.
51. Carthy D, Hajeer A, Ollier B, et al. Mannose-binding lectin gene polymorphism in Greek systemic lupus erythematosus patients. Br J Rheumatol 1997;36:1238-9.
52. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9.
53. Cutler AJ, Botto M, van Essen D, et al. T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med 1998; 187:1789-97.